Literature DB >> 29560584

In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Larissa Bueno Tofani1, Lívia Vieira Depieri1, Patrícia Mazureki Campos1, Thalita Bachelli Riul1, Kamilla Swiech Antonietto1, Márcia Carvalho de Abreu Fantini2, Maria Vitória Lopes Badra Bentley3.   

Abstract

PURPOSE: Vitiligo is a skin disease characterized by depigmentation and the presence of white patches that are associated with the loss of melanocytes. The most common explanation for the cause of this condition is that it is an autoimmune condition. TyRP-1 is involved in melanin pigment synthesis but can also function as a melanocyte differentiation antigen. This protein plays a role in the autoimmune destruction of melanocytes, which results in the depigmentation, characteristic of this disease. In this study, we evaluated liquid crystalline nanodispersions as non-viral vectors to deliver siRNA-TyRP-1 as an alternative for topical treatment of vitiligo.
METHODS: Liquid crystalline nanodispersions were obtained and characterized with respect to their physical-chemical parameters including size, PdI and zeta potential, as well as Small Angle X-ray Scattering and complexing to siRNA. The effects of the liquid crystalline nanodispersions on the cellular viability, cell uptake and levels of the knockdown target TyRP-1 were evaluated in melan-A cells after 24 h of treatment.
RESULTS: The liquid crystalline nanodispersions demonstrated adequate physical-chemical parameters including nanometer size and a PdI below 0.38. These systems promoted a high rate of cell uptake and an impressive TyRP-1 target knockdown (> 80%) associated with suitable loading of TyRp-1 siRNA.
CONCLUSIONS: We demonstrated that the liquid crystalline nanodispersions showed promising alternative for the topical treatment of vitiligo due to their physical parameters and ability in knockdown the target protein involved with autoimmune destruction of melanocytes.

Entities:  

Keywords:  TyRP-1; in vitro knockdown; liquid crystalline nanodispersions; siRNA; vitiligo

Mesh:

Substances:

Year:  2018        PMID: 29560584     DOI: 10.1007/s11095-017-2330-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  52 in total

Review 1.  Lyotropic liquid crystal systems in drug delivery.

Authors:  Chenyu Guo; Jun Wang; Fengliang Cao; Robert J Lee; Guangxi Zhai
Journal:  Drug Discov Today       Date:  2010-10-08       Impact factor: 7.851

2.  Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer.

Authors:  Idit Amar-Yuli; Ellen Wachtel; Einav Ben Shoshan; Dganit Danino; Abraham Aserin; Nissim Garti
Journal:  Langmuir       Date:  2007-03-01       Impact factor: 3.882

3.  Development of a simple, biocompatible and cost-effective Inulin-Diethylenetriamine based siRNA delivery system.

Authors:  C Sardo; R Farra; M Licciardi; B Dapas; C Scialabba; G Giammona; M Grassi; G Grassi; G Cavallaro
Journal:  Eur J Pharm Sci       Date:  2015-04-04       Impact factor: 4.384

Review 4.  Glycerol monooleate liquid crystalline phases used in drug delivery systems.

Authors:  Spomenka Milak; Andreas Zimmer
Journal:  Int J Pharm       Date:  2014-12-03       Impact factor: 5.875

5.  Polyion complex micelles composed of pegylated polyasparthydrazide derivatives for siRNA delivery to the brain.

Authors:  Hong Huo; Yikun Gao; Ying Wang; Jinghai Zhang; Zhan-You Wang; Tongying Jiang; Siling Wang
Journal:  J Colloid Interface Sci       Date:  2015-01-29       Impact factor: 8.128

6.  Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.

Authors:  Markus Benfer; Thomas Kissel
Journal:  Eur J Pharm Biopharm       Date:  2011-11-10       Impact factor: 5.571

7.  Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.

Authors:  Yanran Liang; Zhonglin Liu; Xintao Shuai; Weiwei Wang; Jun Liu; Wei Bi; Chuanming Wang; Xiuna Jing; Yunyun Liu; Enxiang Tao
Journal:  Biochem Biophys Res Commun       Date:  2012-04-21       Impact factor: 3.575

8.  Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.

Authors:  Archana Swami; Ritu Goyal; Sushil Kumar Tripathi; Naresh Singh; Neeraj Katiyar; Anil K Mishra; K C Gupta
Journal:  Int J Pharm       Date:  2009-03-19       Impact factor: 5.875

9.  Modified gold nanoparticles for intracellular delivery of anti-liver cancer siRNA.

Authors:  Hanan Shaat; Amany Mostafa; Moustafa Moustafa; Amira Gamal-Eldeen; Ahmed Emam; Enas El-Hussieny; Mahmoud Elhefnawi
Journal:  Int J Pharm       Date:  2016-03-29       Impact factor: 5.875

10.  In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis.

Authors:  Dagmar Fischer; Youxin Li; Barbara Ahlemeyer; Josef Krieglstein; Thomas Kissel
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  3 in total

1.  Transcriptome and Differential Methylation Integration Analysis Identified Important Differential Methylation Annotation Genes and Functional Epigenetic Modules Related to Vitiligo.

Authors:  Yihuan Pu; Xuenuo Chen; Yangmei Chen; Lingzhao Zhang; Jiayi Chen; Yujie Zhang; Xinyi Shao; Jin Chen
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

Review 2.  Novel Pharmaceutical Strategies for Enhancing Skin Penetration of Biomacromolecules.

Authors:  Luyu Zhang; Zirong Dong; Wenjuan Liu; Xiying Wu; Haisheng He; Yi Lu; Wei Wu; Jianping Qi
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-16

Review 3.  siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.

Authors:  Saman Sargazi; Rabia Arshad; Reza Ghamari; Abbas Rahdar; Ali Bakhshi; Sonia Fathi Karkan; Narges Ajalli; Muhammad Bilal; Ana M Díez-Pascual
Journal:  Cell Biol Int       Date:  2022-07-13       Impact factor: 4.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.